Skip to main content
MAZE logo

Maze Therapeutics, Inc.

MAZENASDAQHealthcareBiotechnology

$31.69Today:- (-)1Y +6.86%

As of Oct 27, 2026 close

Market cap
$1.87B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$21.95$53.65
Volume (live)
-
Avg. volume (3M)
929.47K

Maze Therapeutics (MAZE) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Maze Therapeutics used $111.94M of cash in operating activities and spent $794.00K on capital expenditures. That left free cash flow of −$112.73M.

Maze Therapeutics Cash Flow Statement Analysis

Values in millions USD

Income StatementBalance SheetCash FlowRatios
Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Maze Therapeutics, Inc. (MAZE) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2024FY 2023FY 2022
Period endingDec 2025Mar 2025Dec 2024Dec 2023Dec 2022
Operating Activities
Net Income-131.1252.2352.23-100.42-114.94
Depreciation & Amortization2.403.303.304.093.82
Stock Based Compensation16.409.659.658.756.74
Change in Working Capital-2.27-1.52-1.52-6.32-3.24
Change in Accounts Payable-0.03-0.20-0.200.40-3.78
Change in Other Working Capital2.65-1.323.47-6.720.54
Other Operating Activities2.6512.303.477.078.42
Net Cash from Operating Activities-111.9475.9575.95-86.83-99.20
Investing Activities
Capital Expenditures-0.79-1.15-1.15-0.44-1.97
Acquisitions0.000.00-0.00-1.20
Purchases of Investments-187.670.00-0.000.00
Sales/Maturities of Investments17.500.00-0.000.00
Net Cash from Investing Activities-170.96-1.15-1.15-0.44-3.17
Financing Activities
Debt Repayment0.0024.48-16.180.00
Common Stock Issued270.2868.370.730.211.73
Other Financing Activities-0.500.00-3.150.000.00
Net Cash from Financing Activities275.3492.8592.8516.391.73
Summary
Net Change in Cash-7.57167.65167.65-70.88-100.65
Cash at Beginning of Period197.9030.2530.25101.13201.77
Cash at End of Period190.34197.90197.9030.25101.13
Free Cash Flow-112.7374.8174.81-87.27-101.17
Supplemental Disclosures
Income Taxes Paid--1.23--

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Maze Therapeutics Cash Flow

What is Maze Therapeutics's free cash flow?

Maze Therapeutics had negative free cash flow of $112.73M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$111.94M minus $794.00K of capital expenditures.

How much does Maze Therapeutics spend on capital expenditures?

Maze Therapeutics spent $794.00K on capital expenditures in fiscal 2025, compared with $1.15M a year earlier.

Does Maze Therapeutics pay dividends or buy back shares?

Maze Therapeutics's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition